Biomedical Engineering Reference
In-Depth Information
lipoproteins and von Willebrand factor in chronic renal failure. h romb. Haemost. 76:
663-669.
Horkko, S. and M.J. Savolainen, K. Kervinen, and Y.A. Kesaniemi. 1992. Carbamylation-
induced alterations in low-density lipoprotein metabolism. Kidney Int. 41: 1175-1181.
Horkko, S. and K. Huttunen, K. Kervinen, and Y.A. Kesaniemi. 1994. Decreased clearance
of uraemic and mildly carbamylated low-density lipoprotein. Eur. J. Clin. Invest. 24:
105-113.
Inoue, K. and Y. Arai, H. Kurihara, T. Kita, and T. Sawamura. 2005. Overexpression of lectin-
like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy
in apolipoprotein E-null mice. Circ. Res. 97: 176-184.
Kohno, H. and N. Sueshige, K. Oguri, H. Izumidate, T. Masunari, M. Kawamura, H. Itabe, T.
Takano, A. Hasegawa, and R. Nagai. 2000. Simple and practical sandwich-type enzyme
immunoassay for human oxidatively modii ed low density lipoprotein using antioxidized
phosphatidylcholine monoclonal antibody and antihuman apolipoprotein-B antibody.
Clin. Biochem. 33: 243-253.
Kraus, L.M. and A.P. Kraus, Jr. 2001. Carbamoylation of amino acids and proteins in uremia.
Kidney Int. Suppl. 78: S102-107.
Levey, A.S. and J. Coresh, E. Balk, A.T. Kausz, A. Levin, M.W. Stef es, R.J. Hogg, R.D.
Perrone, J. Lau, and G. Eknoyan. 2003. National Kidney Foundation practice guidelines
for chronic kidney disease: evaluation, classii cation, and stratii cation. Ann. Intern.
Med. 139: 137-147.
Li, D. and J.L. Mehta. 2000. Antisense to LOX-1 inhibits oxidized LDL-mediated
upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human
coronary artery endothelial cells. Circulation 101: 2889-2895.
Lonn, E. 2001. Do antioxidant vitamins protect against atherosclerosis? h e proof is still
lacking. J. Am. Coll. Cardiol. 38: 1795-1798.
Nilsson, L. and P. Lundquist, B. Kagedal, and R. Larsson. 1996. Plasma cyanate concentrations
in chronic renal failure. Clin. Chem. 42: 482-483.
Ok, E. and A.G. Basnakian, E.O. Apostolov, Y.M. Barri, and S.V. Shah. 2002. Elevation of
both carbamylated LDL and autoantibody to carbamylated LDL in dialysis patients. J.
Am. Soc. Nephrol. 13: 219A.
Ok, E. and A.G. Basnakian, E.O. Apostolov, Y.M. Barri, and S.V. Shah. 2005. Carbamylated
low-density lipoprotein induces death of endothelial cells: a link to atherosclerosis in
patients with kidney disease. Kidney Int. 68: 173-178.
Qian, M. and J.W. Eaton, and S.P. Wolf . 1997. Cyanate-mediated inhibition of neutrophil
myeloperoxidase activity. Biochem. J. 326 (Pt 1): 159-166.
Sarnak, M.J. and A.S. Levey, A.C. Schoolwerth, J. Coresh, B. Culleton, L.L. Hamm, P.A.
McCullough, B.L. Kasiske, E. Kelepouris, M.J. Klag, P. Parfrey, M. Pfef er, L. Raij, D.J.
Spinosa, and P.W. Wilson. 2003. Kidney disease as a risk factor for development of
cardiovascular disease: a statement from the American Heart Association Councils on
Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology,
and Epidemiology and Prevention. Circulation 108: 2154-2169.
Sawamura, T. and N. Kume, T. Aoyama, H. Moriwaki, H. Hoshikawa, Y. Aiba, T. Tanaka,
S. Miwa, Y. Katsura, T. Kita, and T. Masaki. 1997. An endothelial receptor for oxidized
low-density lipoprotein. Nature 386: 73-77.
